Valuation: InspireMD, Inc.

Market Cap 29.23M 26.62M 24.53M 22.31M 41.86M 2.71B 44M 299M 119M 1.48B 110M 107M 4.64B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 29.23M 26.62M 24.53M 22.31M 41.86M 2.71B 44M 299M 119M 1.48B 110M 107M 4.64B EV / Sales 2026 *
2.98x
EV / Sales 2027 * 1.78x
Free-Float
69.28%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: InspireMD, Inc.

1 day-12.97%
1 week-16.16%
Current month+20.00%
1 month+20.51%
3 months-39.99%
6 months-47.57%
Current year-69.66%
1 week 0.5
Extreme 0.49985
0.69
1 month 0.43
Extreme 0.431
0.82
Current year 0.43
Extreme 0.4254
1.98
1 year 0.43
Extreme 0.4254
2.17
3 years 0.43
Extreme 0.4254
3.8
5 years 0.43
Extreme 0.4254
3.85
10 years 0.43
Extreme 0.4254
104,734.98
Manager TitleAgeSince
Chief Executive Officer 62 2019-12-31
Director of Finance/CFO 58 2025-06-24
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 2017-06-01
Director/Board Member 68 2013-02-06
Director/Board Member 62 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/18/26 Others

Director

-183,746 0.3952%
9/18/26
Osiris Investment Partners LLC
OthersCompany -262,500 0.5646%
9/18/26 Others

Director

-91,874 0.1976%
Change 5-day change 1-year change 3-year change Capi.($)
-12.97%-16.16%-72.02%-78.82% 29.23M
-0.84%-5.09%-19.60%+1.07% 178B
-0.67%-2.84%-1.25%+27.12% 122B
-0.98%+0.12%-15.82%+5.56% 118B
-1.24%-4.25%-42.94%-1.34% 88.1B
-0.63%-5.55%-7.27%+70.54% 64.71B
+0.05%-2.41%+10.41%-9.90% 57.96B
-1.95%-3.98%-6.85%+41.55% 53.28B
-2.91%-4.35%-0.97%+38.45% 47.8B
-1.64%+1.50%+1.30%-2.04% 35.65B
Average -2.38%-3.98%-15.50%+9.22% 77B
Weighted average by Cap. -1.04%-2.97%-12.44%+15.68%

Financials

2026 *2027 *
Net sales 9.82M 8.94M 8.24M 7.5M 14.07M 909M 14.78M 100M 39.87M 497M 36.85M 36.07M 1.56B 16.41M 14.95M 13.77M 12.53M 23.5M 1.52B 24.7M 168M 66.62M 830M 61.57M 60.27M 2.6B
Net income - -
Net Debt - -
Projected Income Statement - Annual - InspireMD, Inc.
Logo InspireMD, Inc.
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Employees
127
Date Price Change Volume
26-11-20 US$0.5400 -12.97% 634,003
26-11-19 US$0.6205 -9.50% 400,194
26-11-18 US$0.6856 +5.48% 501,936
26-11-17 US$0.6500 +8.33% 496,426
26-11-16 US$0.6000 -6.85% 322,491
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.5400USD
Average target price
2.667USD
Spread / Average Target
+393.83%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - InspireMD, Inc.
  1. Stock Market
  2. Stocks
  3. NSPR Stock